Author:
Desramé J.,Duvic C.,Bredin C.,Béchade D.,Artru P.,Brézault C.,Defuentes G.,Poirier J.M.,Dourthe L.M.,Coutant G.,Chaussade S.,de Gramont A.,Algayres J.P.
Subject
Gastroenterology,Internal Medicine
Reference33 articles.
1. Gemcitabine safety overview;Green;Semin. Oncol.,1996
2. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer : a phase II study;Anderson;J. Clin. Oncol.,1994
3. Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer;Stadler;J. Clin. Oncol.,1997
4. Locoregional/systemic chemotherapy of locally advanced/metastazied pancreatic cancer with a combination of mitomycin-C ang gemcitabine and simultaneous follow-up by imaging methods and tumor markers;Klapdor;Anticancer Res.,1999
5. Gemcitabine as a single-agent in the treatment of relapsed or refractory low-grade non-Hodgkin‘s lymphoma;Dumontet;Br. J. Haematol.,2001
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献